X-Therma’s $22.4M Series B sets stage to transform regenerative medicine and organ transplantation
X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has completed an oversubscribed $22.4 million Series ...
Read moreDetails